Short-term Intervention and Health Trajectories After Mass Trauma

The Landslide Disaster in Gjerdrum Municipality: Early Intervention and Health Trajectories After Mass Trauma

This study has two aims. The first is to understand more of what may be typical health trajectories after mass trauma for children and adults and what predicts these trajectories. The second is to understand what may be effective early interventions to prevent long-term health and psychosocial problems for youth (6-19). Participants are recruited from an outreach program implemented after a landslide killed 11 persons and destroyed 33 houses in Gjerdrum in Norway. One third of the inhabitants were evacuated. All evacuated are contacted and screened for trauma related difficulties. Those who have significant post-trauma reactions are offered trauma focused interventions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Two short step-wise interventions are developed for this study as an early intervention after mass trauma based on components from TF-CBT to test the relative importance of dosage and the sequencing of components.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway
        • Norwegian Center for Violence and Traumatic Stress Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 19 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Exposed to the landslide
  • Between 6-19 years old
  • A score of 15 or more on the CATS
  • A score between 11 - 14 on the CATS and have additional problems that have started or worsened after the landslide.

Exclusion Criteria:

  • Suicidal
  • Psychotic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TF-CBT-Skills
Step 1: 4-5 sessions with stabilization/skill building Step 2: 4-5 sessions with narrative and cognitive processing
Participants receive either 4-5 sessions of TF-CBT-Skills or TF-CBT-Narr. If the participant still has significant PTSS they are provided with step two which is the components provided in the arm they did not receive.
Active Comparator: TF-CBT-Narr
Step 1: 4-5 sessions with narrative and cognitive processing Step 2: 4-5 sessions with stabilization/skill building
Participants receive either 4-5 sessions of TF-CBT-Skills or TF-CBT-Narr. If the participant still has significant PTSS they are provided with step two which is the components provided in the arm they did not receive.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD
Time Frame: Pre-treatment
Measured with the Child and adolescent trauma screen (CATS). Range 0-60. Higher score means worse outcome.
Pre-treatment
PTSD
Time Frame: After 5 weeks
Measured with the CATS (after 4-5 sessions)
After 5 weeks
PTSD
Time Frame: After 9 weeks
Measured with the CATS (for those who continue to Step two)
After 9 weeks
PTSD
Time Frame: After 21 weeks
Measured with the CATS
After 21 weeks
PTSD
Time Frame: After 33 weeks
Measured with the CATS
After 33 weeks
PTSD
Time Frame: After 45 weeks
Measured with the CATS
After 45 weeks
PTSD
Time Frame: After 57 weeks
Measured with the CATS
After 57 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: Pre-treatment
Measured with Moods and feelings questionaire (MFQ-short). Range 0-13. Higher scores means worse outcome.
Pre-treatment
Depression
Time Frame: After 5 weeks
Measured with MFQ-short
After 5 weeks
Depression
Time Frame: After 9 weeks
Measured with MFQ-short
After 9 weeks
Depression
Time Frame: After 21 weeks
Measured with MFQ-short
After 21 weeks
Depression
Time Frame: After 33 weeks
Measured with MFQ-short
After 33 weeks
Depression
Time Frame: After 45 weeks
Measured with MFQ-short
After 45 weeks
Depression
Time Frame: After 57 weeks
Measured with MFQ-short
After 57 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: Pre-treatment
Measured with Screen for Child Anxiety Related Emotional Disorders (SCARED-5 Item)
Pre-treatment
Anxiety
Time Frame: After 5 weeks
Measured with SCARED-5 Item
After 5 weeks
Anxiety
Time Frame: After 9 weeks
Measured with SCARED-5 Item
After 9 weeks
Anxiety
Time Frame: After 21 weeks
Measured with SCARED-5 Item
After 21 weeks
Anxiety
Time Frame: After 33 weeks
Measured with SCARED-5 Item
After 33 weeks
Anxiety
Time Frame: After 45 weeks
Measured with SCARED-5 Item
After 45 weeks
Anxiety
Time Frame: After 57 weeks
Measured with SCARED-5 Item
After 57 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tine K Jensen, PhD, Norwegian Center for Violence and Traumatic Stress Studies

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2021

Primary Completion (Actual)

August 1, 2022

Study Completion (Actual)

March 15, 2023

Study Registration Dates

First Submitted

March 14, 2021

First Submitted That Met QC Criteria

September 2, 2021

First Posted (Actual)

September 13, 2021

Study Record Updates

Last Update Posted (Actual)

May 16, 2023

Last Update Submitted That Met QC Criteria

May 13, 2023

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Clinical Trials on TF-CBT-Short

3
Subscribe